Hospital medicine

hospital and acute care

The week's innovation in hospital medicine, published every Sunday for the week before: new technology, AI tools, devices, FDA decisions on new technology and new ways of delivering care, every item linked to its sources.

Deprescribing stewardship gives small gain in older inpatients; FDA approves asundexian after stroke; Arrow guidewires and Alaris sets flagged

A hospital bed in side view with the head section raised, a pillow, wheels and a side rail carrying a small call button.

A Drug Burden Index stewardship bundle raised deprescribing of anticholinergic or sedative drugs at discharge by 5.3 percentage points in 4,827 older inpatients, less than hypothesized, in a trial published Nov. 9.

The Food and Drug Administration (FDA) approved asundexian, the first factor XIa inhibitor, after mild-to-moderate stroke, flagged Arrow guidewires whose coating may embolize and classed a correction of kits with BD Alaris infusion sets as its most serious recall type.

  • Research Nov 9, 2026
    In a stepped-wedge cluster randomized trial in six Australian public hospitals, published Nov. 9 in JAMA Internal Medicine, a Drug Burden Index stewardship bundle raised the share of older inpatients with at least one anticholinergic or sedative drug deprescribed at discharge to 41.4% from 38.1% in the control phase, an adjusted difference of 5.3 percentage points (95% CI 0.1 to 10.6), smaller than hypothesized. The rate fell to 37.0% once the stewardship component ended. Deprescribing recommendations in discharge summaries rose to 23.4% from 14.6%, and in-hospital adverse events were similar across phases.
  • FDA Nov 9, 2026
    The Food and Drug Administration (FDA) on Nov. 9 approved Sunharbo (asundexian) 50 mg, the first factor XIa inhibitor, for use with antiplatelet therapy after a recent mild-to-moderate non-cardioembolic ischemic stroke or high-risk transient ischemic attack, after a 26% reduction in ischemic stroke versus placebo in 12,327 adults. Overall major bleeding was similar, but it was increased in patients older than 75 and in the first 90 days. The drug should be withheld at least 24 hours before elective surgery or invasive procedures and is not recommended in moderate or severe hepatic impairment.
    Source: FDA
  • FDA Nov 10, 2026
    The Food and Drug Administration (FDA) on Nov. 10 posted an early alert on Arrow International hydrophilic-coated guidewires and the pressure-injectable catheters containing them. Teleflex confirmed the coating may swell inconsistently when hydrated with saline, leading to clumping and potential detachment, and hydrophilic polymer emboli may cause thrombosis, ischemia, stroke or death. The company's Nov. 5 letter told customers to stop use, quarantine and return affected product; it reported no serious injuries or deaths.
    Source: FDA
  • FDA Nov 9, 2026
    The Food and Drug Administration (FDA) on Nov. 9 classified Cardinal Health's correction of Presource kits containing BD Alaris Pump infusion sets, an update to use instructions, as a Class I recall, its most serious type, updating an Oct. 20 early alert. Set performance deviations, most often at rates under 1 mL/h and bolus volumes of 5 mL or less, can cause under- or over-infusion, with critically ill patients among those at highest risk. FDA lists an alternative syringe pump among options; BD reported no serious injuries or deaths as of Aug. 19.
    Source: FDA

Latest news

Tagged hospital medicine, from the daily briefing

  1. A needle-free IV valve can stay open after disconnection, risking blood loss and air embolism, FDA warns
  2. AI-assisted bedside ultrasound did as well as visual reads and E-point septal separation at spotting reduced ejection fraction across 28 studies
  3. San Juan Regional Medical Center uses Elsevier's ClinicalKey AI, now with patient EHR context

See all the latest news

Earlier weeks

The weekly podcast

Each Sunday's hospital medicine innovation roundup as a short audio briefing, read by AI voices. Play any episode here, or follow the show in any podcast app.

In any podcast app, add the feed: https://feeds.transistor.fm/physician-in-the-loop-hospital-medicine